Brain cell origin solved

Brain macrophages are derived from cells in the embryonic yolk sac, finally solving an ongoing controversy in neuroscience

Written byJef Akst
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share
New findings lay to rest a debate over the origin and cell lineage of macrophages found in mouse brains -- they come from progenitor cells in the embryonic yolk sac and are self-renewing, and are not derived from bone marrow precursors like other macrophages in the body.
A mouse macrophage
Image: Wikimedia commons, Obli
The results, published online today (21 October) in Science Express, may also hold implications for the treatment of neurodegenerative diseases."It has been quite controversial where [microglia] come from in embryonic life," said neurologist linkurl:Richard Ransohoff;http://my.clevelandclinic.org/staff_directory/staff_display.aspx?doctorid=814 of the Cleveland Clinic, who was not involved in the research. This study "showed unequivocally that microglia come from these yolk sac progenitors."Microglia are macrophages that reside in the central nervous system. They are important for maintaining healthy brain function and have been associated with many neurodegenerative and brain inflammatory diseases, but where they come from -- both initially and throughout life -- has been a bit of mystery. Some mice studies suggested that they could be replaced by bone marrow progenitor cells, but a couple of papers linkurl:published in Nature Neuroscience;http://www.nature.com/neuro/journal/v10/n12/index.html in 2007 suggested that these experiments, which involved irradiating the animals, introduced artifacts and were "completely un-physiological," Ransohoff explained. Whether or not the bone marrow could contribute to the microglia in the brain under normal conditions has remained unclear, as has where the microglia cells came from initially.To answer these questions, immunologist linkurl:Miriam Merad;http://www.mountsinai.org/profiles/miriam-merad of the Mount Sinai School of Medicine in New York and her colleagues created mice with green fluorescent protein (GFP) attached to the fractalkine receptor (CX3CR1), which is found on early myeloid progenitors and microglia. Monitoring the mice, they saw evidence of microglia when the embryos were around 10.5 days old, and the phenotype of the cells suggested they were derived from the yolk sac.To confirm this, the researchers labeled the yolk sac cells with yellow fluorescent protein (YFP) at various times throughout development, and watched where they went. They found that some myeloid progenitor cells in the yolk sac indeed became microglia, and the cells that give rise to microglia are produced in a very limited time window, around days 7 to 8 of embryonic development. Furthermore, only a few percent of circulating and non-brain tissue macrophages carried the YFP label, suggesting they were derived from another source. "The paper is highly influential," developmental neuroscientist linkurl:Payam Rezaie;http://www.open.ac.uk/science/lifesciences/people/people-profile.php?staff_id=Payam%26%26Rezaie of The Open University in the UK, who did not participate in the research, told The Scientist in an email. The authors went on to show that bone marrow progenitor cells do not contribute to the microglia in the healthy adult brains, in contrast to when the mice are irradiated. This supports the notion that resident microglia (i.e. the embryo-derived cell population) are maintained independently through self-renewal."In a normal healthy animal, the majority of cells that appear to populate the adult brain are derived from the yolk sac in the embryo...and they persist for a long time," said neuroimmunologist linkurl:Hugh Perry;http://www.southampton.ac.uk/biosci/about/staff/vhp.page of the University of Southampton, who was not involved in the study. What this means for the function of these cells is unclear, however, he added. After irradiation, for example, bone-marrow derived cells that look like microglia do end up in the brain, meaning that "macrophage cells have the capacity to enter the brain and adopt the morphology of microglia" under some conditions, Perry said. The results could have therapeutic implications for neurological diseases, said Ransohoff. "Your strategy for dealing with the bad consequences of microglial or macrophage activation in neurological disease are going to depend on where you think they came from," he said. If the cells are coming from the bone marrow, a logical solution would be to block them from getting to the brain in the first place, he explained. On the other hand, if the resident microglia are the problem, they are already in the brain, so "you have to come up with compounds that directly address microglial activation," he said. "Those are two totally different therapeutic strategies."Additionally, this research emphasizes the importance of embryonic work, study author Merad told The Scientist. "Our work reveals that there are processes that only occur during early embryonic life," she said. "That shows that we need to work on embryos if we want to understand all the molecular program to make these cells..[and] the biology of these brain diseases."F. Ginhoux, et al., "Fate mapping analysis reveals that adult microgliaderive from primitive macrophages," linkurl:SciencExpress,;http://www.sciencexpress.org 10.1126/science.1194637, 2010.
**__Related stories:__***linkurl:Immunology 2.0: brain, gut?;http://www.the-scientist.com/blog/display/57499/
[18th June 2010]*linkurl:Of cells and wires;http://www.the-scientist.com/article/display/55313/
[January 2009]*linkurl:Alzheimer plaques precede neuron damage;http://www.the-scientist.com/blog/display/54288/
[6th February 2008]
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Jef (an unusual nickname for Jennifer) got her master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses. After four years of diving off the Gulf Coast of Tampa and performing behavioral experiments at the Tennessee Aquarium in Chattanooga, she left research to pursue a career in science writing. As The Scientist's managing editor, Jef edited features and oversaw the production of the TS Digest and quarterly print magazine. In 2022, her feature on uterus transplantation earned first place in the trade category of the Awards for Excellence in Health Care Journalism. She is a member of the National Association of Science Writers.

    View Full Profile
Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 
Illustrated plasmids in bright fluorescent colors

Enhancing Elution of Plasmid DNA

cytiva logo
An illustration of green lentiviral particles.

Maximizing Lentivirus Recovery

cytiva logo

Products

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery